e-learning
resources
Munich 2006
Sunday 03.09.2006
Dealing with chronic allograft dysfunction: mission impossible?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Simvastatin potentially reduces airway neutrophilia & remodelling in lung allografts
D. M. Murphy, I. A. Forrest, C. Ward, P. A. Corris, D. Jones, G. E. Johnson, A. J. Fisher, J. J. Egan, T. E. Cawston, J. L. Lordan (Newcastle, United Kingdom; Dublin, Ireland)
Source:
Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Session:
Dealing with chronic allograft dysfunction: mission impossible?
Session type:
Oral Presentation
Number:
777
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. M. Murphy, I. A. Forrest, C. Ward, P. A. Corris, D. Jones, G. E. Johnson, A. J. Fisher, J. J. Egan, T. E. Cawston, J. L. Lordan (Newcastle, United Kingdom; Dublin, Ireland). Simvastatin potentially reduces airway neutrophilia & remodelling in lung allografts. Eur Respir J 2006; 28: Suppl. 50, 777
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Acute viral bronchiolitis and acute asthma
Management of bronchiolitis for winter 2017/2018-What is in and what is out)
Acute bronchiolitis – prevention, diagnosis, and new approaches to management
Related content which might interest you:
Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD
Source: Eur Respir J 2011; 38: 789-796
Year: 2011
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Glucagon inhibits airway hyperreactivity and lung inflammation in a murine model of acute lung injury
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1208-1211
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1211-1212
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2013; 42: 350-361
Year: 2013
Inhaled insulin does not trigger lung inflammation and airway remodelling
Source: Eur Respir J 2009; 33: 444-445
Year: 2009
Effects of corticosteroid or montelukast associated to iNOS inhibitior on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2011 - Translational models of disease
Year: 2011
Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007
Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011
Dexamethasone reduces lung inflammation induced by alveolar stretch in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
The association between LASSBio596 and surfactant improves lung morpho-function and reduces the inflammatory process in experimental sepsis-induced acute lung injury
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept